1.
Efficacy Levels of Recombinant Tetravalent Dengue Vaccine (Cyd-Tdv) in Children Aged 2-16 Years: Meta-Analysis. JISIP. 2024;8(3):1583-1591. doi:10.58258/jisip.v8i3.6988